Le Lézard
Classified in: Covid-19 virus
Subjects: Photo/Multimedia, Product/Service, Corporate Social Responsibility

Fifth Third Commits $8.75 Million to Address Effects of COVID-19


Fifth Third today announced an $8.75 million philanthropic commitment to help address the effects of the COVID-19 pandemic. The funds from the Fifth Third Foundation and the Fifth Third Chicagoland Foundation will be deployed to meet the immediate and long-term needs of the communities served by Fifth Third Bank.

"We are making this $8.75 million philanthropic commitment to support the needs of our community members," said Greg D. Carmichael, chairman, president and CEO of Fifth Third Bank. "This pandemic is impacting all segments of the population, especially the most vulnerable members of our communities who may be disproportionately affected by current events. It is our responsibility and commitment to work with community partners and non-profit organizations to help see our communities through the coming stages of relief, recovery and resiliency. We will navigate this together."

The $8.75 million commitment is being funded by the Fifth Third Foundation and the Fifth Third Chicagoland Foundation. Among the areas to be funded:

Relief Funds:

Recovery & Resiliency Funds:

This $8.75 million commitment of philanthropic funds from the Fifth Third Foundation and the Fifth Third Chicagoland Foundation are in addition to actions already taken by Fifth Third Bank to immediately assist customers in the wake of the pandemic. For information, visit www.53.com/covid19.

About the Fifth Third Foundation

Established in 1948, the Fifth Third Foundation was one of the first charitable foundations created by a financial institution. The Fifth Third Foundation supports worthy causes in the areas of health and human services, education, community development and the arts in the states where Fifth Third Bank operates.


These press releases may also interest you

at 12:50
Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired QuidelOrtho Corporation ("QuidelOrtho"...

at 11:40
The "Global Needle Coke Market: Focus on Application, Type, Grade, End Use, and Country-Level Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global needle coke market was valued at $3.05...

at 11:15
Expomed Eurasia, the most important medical exhibition between Europe and Asia, is ready to house more than a hundred companies, to discover new technological trends and the most innovative products which are going to change deeply the health market....

at 11:15
Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product. Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialization of NIOPEG® (a...

at 09:35
Two large multi-state studies uncovered a highly effective way to improve antibiotic selection for patients hospitalized with pneumonia or urinary tract infections (UTI), enabling better antibiotic stewardship in hospitals, according to research...

at 09:25
The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth analyses of: the scope of telehealth usage in the U.S., telehealth user demographics, pros and...



News published on and distributed by: